Tomás G. Lyons
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
- PARP inhibition in cancer therapy 4
- Cancer Immunotherapy and Biomarkers 3
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- Geoffrey Y. Ku (2 shared papers)Tiffany A. Traina (5 shared papers)Mark E. Robson (1 shared paper)Grainne M. O’Kane (2 shared papers)Catherine M. Kelly (3 shared papers)Cynthia Heffron (1 shared paper)Gabrielle Colleran (1 shared paper)Linda Feeley (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Breast Cancer Research and Treatment (2 papers)European Journal of Cancer (2 papers)Current Oncology Reports (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- United StatesIreland
In The Last Decade
Tomás G. Lyons
18 papers receiving 439 citations
Peers
Comparison fields: 5 of 68
- Oncology 219
- Cancer Research 96
- Pulmonary and Respiratory Medicine 106
- Molecular Biology 219
- Immunology 60
Countries citing papers authored by Tomás G. Lyons
This map shows the geographic impact of Tomás G. Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás G. Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás G. Lyons more than expected).
Fields of papers citing papers by Tomás G. Lyons
This network shows the impact of papers produced by Tomás G. Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás G. Lyons. The network helps show where Tomás G. Lyons may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomás G. Lyons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 242 | |
| 2 | 2020 | 30 | |
| 3 | 2017 | 30 | |
| 4 | 2014 | 27 | |
| 5 | 2016 | 22 | |
| 6 | 2018 | 17 | |
| 7 | 2019 | 17 | |
| 8 | 2017 | 17 | |
| 9 | 2014 | 11 | |
| 10 | 2018 | 10 | |
| 11 | 2017 | 5 | |
| 12 | Vismodegib in the treatment of advanced BCC. | 2014 | 4 |
| 13 | 2020 | 2 | |
| 14 | 2011 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2013 | 1 | |
| 18 | 2017 | 1 |
About Tomás G. Lyons
Tomás G. Lyons is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Genetics, having authored 18 papers that have together received 442 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), PARP inhibition in cancer therapy (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Melanoma and MAPK Pathways (2 papers), Hedgehog Signaling Pathway Studies (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (219 citations), Cancer Research (96 citations), Pulmonary and Respiratory Medicine (106 citations), Molecular Biology (219 citations) and Immunology (60 citations). Tomás G. Lyons has collaborated with scholars based in United States and Ireland. Frequent co-authors include Geoffrey Y. Ku, Tiffany A. Traina, Mark E. Robson, Grainne M. O’Kane, Catherine M. Kelly, Cynthia Heffron, Gabrielle Colleran, Linda Feeley, Eoin C. Kavanagh and David Fitzpatrick. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, European Journal of Cancer, Current Oncology Reports and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.